Skip to main content
Clinical Trials/EUCTR2011-001034-42-DE
EUCTR2011-001034-42-DEActive, not recruitingNot Applicable

A single visit, observational, follow-up study of Patients with Leber’s Hereditary Optic Neuropathy following participation in SNT-II-003 trial

Santhera Pharmaceuticals (Switzerland) Limited0 sites85 target enrollmentStarted: March 22, 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
85

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •LHON patients who participated in study SNT-II-003
  • •Are the trial subjects under 18? yes
  • •Number of subjects for this age range: 3
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range 41
  • •F.1.3 Elderly (>=65 years) no
  • •F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • •There will be no exclusion criteria.

Investigators

Sponsor
Santhera Pharmaceuticals (Switzerland) Limited

Similar Trials